share_log

Avidity Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Flanagan W. Michael

SEC ·  Dec 14, 2024 07:11
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more